NASDAQ: SNOA 0.93% to $6.51 on Tuesday with shrinking demand for its daily 15,565 shares. Today Sonoma Pharmaceuticals soars more than 80% premarket on probably two million shares.
Investors are experiencing penny biotech stocks instantly soar more than 100% within a week due to speculative news regarding the development of new medicines and vaccines. Largely due to COVID-19 this trend has been occurring since February.
Jumping onto the SNOA bandwagon can’t be late because the pandemic is still spreading over the world by forcing many governments to spend billions on the healthcare system. Sonoma holds several high tech medical patents to develop sanitizing goods, therefore its partners may use them by delivering a significant rise in Sonoma’s revenue.